Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TaoWeave (OBLG) Research & Development (2016 - 2025)

TaoWeave (OBLG) has disclosed Research & Development for 11 consecutive years, with $3000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development fell 92.11% year-over-year to $3000.0, compared with a TTM value of $11000.0 through Sep 2025, down 92.99%, and an annual FY2024 reading of $155000.0, up 675.0% over the prior year.
  • Research & Development was $3000.0 for Q3 2025 at TaoWeave, roughly flat from $3000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.0 million in Q1 2022 and bottomed at $2000.0 in Q4 2024.
  • Average Research & Development over 5 years is $252421.1, with a median of $50000.0 recorded in 2024.
  • The sharpest move saw Research & Development crashed 99.4% in 2023, then skyrocketed 1200.0% in 2024.
  • Year by year, Research & Development stood at $929000.0 in 2021, then crashed by 93.0% to $65000.0 in 2022, then tumbled by 93.85% to $4000.0 in 2023, then crashed by 50.0% to $2000.0 in 2024, then soared by 50.0% to $3000.0 in 2025.
  • Business Quant data shows Research & Development for OBLG at $3000.0 in Q3 2025, $3000.0 in Q2 2025, and $3000.0 in Q1 2025.